Zoledronate (Reclast)

Zoledronic acid · Novartis

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Zoledronate (Reclast), covering 2025-10-02 to 2025-10-02. Get the full timeline:

Most recent: Clinical Trial Update: Treatment With Zoledronate Subsequent to Denosumab in Osteoporosis 2 (ZOLARMAB2) [Phase 4]